Some researchers advocate shortening the procedure for clinical trials to develop a vaccine by infecting healthy volunteers with the live virus. This ‘challenge infection’ method raises an ethical dilemma.
Some researchers advocate shortening the procedure for clinical trials to develop a vaccine by infecting healthy volunteers with the live virus. This ‘challenge infection’ method raises an ethical dilemma.